Konono K, Msusa K, Mpinganjira S, Amani A, Nyagupe C, Ngigi M
Influenza Other Respir Viruses. 2024; 18(11):e70047.
PMID: 39557412
PMC: 11573421.
DOI: 10.1111/irv.70047.
Meng Z, Wang S, Yu L, Zhao K, Wu T, Zhu X
mSystems. 2024; 9(5):e0122223.
PMID: 38564711
PMC: 11097644.
DOI: 10.1128/msystems.01222-23.
Olorunfemi A, Suliman S, Tran T, Ayorinde B, Fowora M, Iwalokun B
IJID Reg. 2024; 10:174-178.
PMID: 38322246
PMC: 10845906.
DOI: 10.1016/j.ijregi.2024.01.005.
Hilti D, Wehrli F, Roditscheff A, Risch M, Risch L, Egli A
Pathogens. 2023; 12(12).
PMID: 38133268
PMC: 10745585.
DOI: 10.3390/pathogens12121383.
Chaves-Blanco L, De Salazar A, Fuentes A, Vinuela L, Perez-Florido J, Dopazo J
Epidemiol Infect. 2023; 151:e201.
PMID: 37997654
PMC: 10753446.
DOI: 10.1017/S095026882300184X.
Epidemiologic investigation and genetic characterization of canine respiratory coronavirus in the Southeastern United States.
De Luca E, Alvarez-Narvaez S, Baptista R, Maboni G, Blas-Machado U, Sanchez S
J Vet Diagn Invest. 2023; 36(1):46-55.
PMID: 37968872
PMC: 10734574.
DOI: 10.1177/10406387231213662.
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
Koen A, Izu A, Baillie V, Kwatra G, Cutland C, Fairlie L
Vaccine. 2023; 41(23):3486-3492.
PMID: 37149443
PMC: 10133888.
DOI: 10.1016/j.vaccine.2023.04.058.
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencing.
Pillay S, San J, Tshiabuila D, Naidoo Y, Pillay Y, Maharaj A
PLoS One. 2023; 18(4):e0283219.
PMID: 37099540
PMC: 10132692.
DOI: 10.1371/journal.pone.0283219.
Whole Sequencing and Detailed Analysis of SARS-CoV-2 Genomes in Southeast Spain: Identification of Recurrent Mutations in the 20E (EU1) Variant with Some Clinical Implications.
Lopez-Andreo M, Vicente-Romero M, Bernal E, Navarro-Gonzalez I, Salazar-Martinez F, Canovas-Canovas V
Diseases. 2023; 11(2).
PMID: 37092436
PMC: 10123601.
DOI: 10.3390/diseases11020054.
Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique.
Ismael N, van Wyk S, Tegally H, Giandhari J, San J, Moir M
PLOS Glob Public Health. 2023; 3(3):e0001593.
PMID: 36963096
PMC: 10021167.
DOI: 10.1371/journal.pgph.0001593.
COVIDSeq as Laboratory Developed Test (LDT) for Diagnosis of SARS-CoV-2 Variants of Concern (VOC).
Carpenter R, Tamrakar V, Almas S, Brown E, Sharma R
Arch Clin Biomed Res. 2023; 6(6):954-970.
PMID: 36588916
PMC: 9802674.
DOI: 10.26502/acbr.50170309.
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection.
Arriaga-Canon C, Contreras-Espinosa L, Rebollar-Vega R, Montiel-Manriquez R, Cedro-Tanda A, Garcia-Gordillo J
Int J Mol Sci. 2022; 23(19).
PMID: 36232363
PMC: 9570475.
DOI: 10.3390/ijms231911058.
Simultaneous SARS-CoV-2 Genome Sequencing of 384 Samples on an Illumina MiSeq Instrument through Protocol Optimization.
Papa Mze N, Beye M, Kacel I, Tola R, Basco L, Bogreau H
Genes (Basel). 2022; 13(9).
PMID: 36140815
PMC: 9498777.
DOI: 10.3390/genes13091648.
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
Tegally H, San J, Cotten M, Moir M, Tegomoh B, Mboowa G
Science. 2022; 378(6615):eabq5358.
PMID: 36108049
PMC: 9529057.
DOI: 10.1126/science.abq5358.
Integrating genomic and epidemiologic data to accelerate progress toward schistosomiasis elimination.
Lund A, Wade K, Nikolakis Z, Ivey K, Perry B, Pike H
Elife. 2022; 11.
PMID: 36040013
PMC: 9427098.
DOI: 10.7554/eLife.79320.
The Mutational Landscape of SARS-CoV-2 Variants of Concern Recovered From Egyptian Patients in 2021.
Seadawy M, Binsuwaidan R, Alotaibi B, El-Masry T, El-Harty B, Gad A
Front Microbiol. 2022; 13:923137.
PMID: 35875574
PMC: 9300961.
DOI: 10.3389/fmicb.2022.923137.
Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.
Umunnakwe C, Makatini Z, Maphanga M, Mdunyelwa A, Mlambo K, Manyaka P
PLoS One. 2022; 17(6):e0269071.
PMID: 35749403
PMC: 9231807.
DOI: 10.1371/journal.pone.0269071.
A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus.
Chrzastek K, Tennakoon C, Bialy D, Freimanis G, Flannery J, Shelton H
BMC Genomics. 2022; 23(1):406.
PMID: 35644636
PMC: 9148844.
DOI: 10.1186/s12864-022-08563-z.
Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
Chaki S, Kahl-Mcdonagh M, Neuman B, Zuelke K
Microbiol Spectr. 2022; 10(3):e0066522.
PMID: 35638906
PMC: 9241651.
DOI: 10.1128/spectrum.00665-22.
Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
Goswami C, Sheldon M, Bixby C, Keddache M, Bogdanowicz A, Wang Y
BMC Infect Dis. 2022; 22(1):404.
PMID: 35468749
PMC: 9035976.
DOI: 10.1186/s12879-022-07374-7.